3.8 Article

EnABLing cathepsin-driven melanoma metastasis

Journal

MOLECULAR & CELLULAR ONCOLOGY
Volume 5, Issue 4, Pages -

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/23723556.2018.1458016

Keywords

cathepsin; ABL1; ABL2; Abl; Arg; ETS1; SP1; NF-kappa B; RELA; cysteine cathepsins

Categories

Funding

  1. HHS / NIH / National Cancer Institute (NCI)
  2. NIH [R01CA116784, R01CA166499]
  3. Markey Cancer Foundation Women Strong Award

Ask authors/readers for more resources

Metastatic melanoma remains incurable for many due to its aggressive nature. Secreted cathepsins promote metastasis by cleaving matrix and activating pro-invasive proteases. We reported that ABL kinases induce cathepsin secretion and subsequent metastasis by activating ETS1, SP1, and RELA pathways, indicating that ABL inhibitors may serve as novel anti-cathepsin agents.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available